0.55 %
Get CTIX Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading CTIX now

Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha

IHUB Most Posted And Most Read Stocks Do Not Perform Well
2/11/2015 9:43:00 AM - Seeking Alpha

An Interview With Cellceutix CEO Leo Ehrlich
2/9/2015 10:31:00 AM - Seeking Alpha

Cellceutix: Why An Uplisting Is Not Possible Right Now
2/6/2015 2:26:00 PM - Seeking Alpha

$CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon
1/29/2015 4:13:00 PM - Seeking Alpha

Cellceutix: A December To Remember May Turn Into A 2015 To Forget For CTIX
1/23/2015 10:30:00 AM - Seeking Alpha

Cellceutix Overvalued By 90-99%
1/2/2015 5:21:00 PM - Seeking Alpha

CorMedix Update: Setting A New Standard For Catheter Care
12/28/2014 7:07:00 AM - Seeking Alpha

New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost
12/9/2014 12:49:00 AM - RTT News

Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA
12/8/2014 7:29:00 AM - RTT News

Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix
9/25/2014 10:02:00 AM - Seeking Alpha

Update: Cellceutix Calls Out To President Obama About Brilacidin
9/21/2014 3:38:00 PM - Seeking Alpha

Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol
9/14/2014 3:06:00 AM - Seeking Alpha

The Antibiotic Resistance Triple Threat
9/4/2014 2:05:00 PM - Seeking Alpha

Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?
8/14/2014 11:38:00 AM - Seeking Alpha

Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix
4/25/2014 10:34:00 AM - Seeking Alpha

Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
1/28/2014 9:31:00 AM - Seeking Alpha

Cellceutix: An Undiscovered Company Set To Rise In 2014
12/16/2013 9:06:00 AM - Seeking Alpha